Michele Morales, autor en - Page 10 of 434

How are electrolyzer costs and efficiency improving with new materials?

20 Jul

How has materials science reshaped electrolyzer electrodes and structures to improve economics?

Electrolyzers split water into hydrogen and oxygen using electricity. Their economics determine whether clean hydrogen can compete with fossil-based alternatives across industry, transport, and power storage. Historically, high capital cost and modest efficiency limited deployment. Over the past decade, *materials science* has become the main lever for change, reshaping catalysts, membranes, electrodes, and structural components. The result is a steady drop in system cost per kilowatt and a rise in efficiency and lifetime.Key factors shaping the overall cost of electrolyzersThe cost of an electrolyzer is not driven by any single component, so progress emerges from a range of material enhancements…

Myanmar: CSR supporting workforce training and community well-being programs

20 Jul

Corporate social responsibility in Myanmar fosters workforce training and social welfare

Michele MoralesSocial Responsibility

Myanmar’s private sector, development agencies, and civil society increasingly deploy corporate social responsibility (CSR) to support workforce training and community well-being. These efforts address chronic gaps in skills, health, education, and local livelihoods while seeking sustainable business benefits such as a more skilled labor pool, stronger local supply chains, and improved social license to operate. Programs range from employer-led apprenticeships and digital skills hubs to health clinics, maternal-child programs, and smallholder agricultural support.Context and needMyanmar’s economy has undergone rapid structural change over decades of reform, investment, and crises. Large segments of the workforce lack formal vocational credentials and access to…

19 Jul

How Myanmar’s CSR programs support digital literacy and women’s economic empowerment

Michele MoralesSocial Responsibility

Myanmar’s private sector, development agencies, and civil society increasingly incorporate corporate social responsibility (CSR) to enhance workforce training and strengthen community welfare, tackling persistent shortages in skills, healthcare, education, and local income sources while pursuing sustainable business gains, including a more capable labor force, more resilient local supply chains, and a stronger social license to operate, with initiatives spanning employer-driven apprenticeships, digital training centers, health services, maternal and child programs, and assistance for smallholder farmers.Background and RequirementsMyanmar’s economy has experienced swift structural shifts through years of reform, investment, and recurring crises. Many workers still lack formal vocational qualifications and adequate…

19 Jul

What improvements in membranes and catalysts are key to driving down electrolyzer costs?

Michele MoralesScience and Technology

Electrolyzers split water into hydrogen and oxygen using electricity. Their economics determine whether clean hydrogen can compete with fossil-based alternatives across industry, transport, and power storage. Historically, high capital cost and modest efficiency limited deployment. Over the past decade, *materials science* has become the main lever for change, reshaping catalysts, membranes, electrodes, and structural components. The result is a steady drop in system cost per kilowatt and a rise in efficiency and lifetime.Key factors shaping the overall cost of electrolyzersElectrolyzer cost is not dominated by a single part. Improvements therefore come from multiple material upgrades rather than one breakthrough.Catalysts: precious…

Why are mRNA platforms expanding into new therapeutic areas?

19 Jul

How mRNA platforms are reshaping treatment beyond vaccines

Michele MoralesScience and Technology

Messenger RNA platforms have evolved well past their original role as vaccine tools, extending into oncology, rare conditions, cardiovascular therapies, and other fields as scientific validation, production efficiencies, regulatory experience, and persistent clinical gaps converge. The very attributes that supported swift action during the pandemic are now being applied to transform the way medicines are conceived and delivered.From Proof of Concept to Broad Clinical ConfidenceThe worldwide rollout of mRNA vaccines offered extensive real-world confirmation that synthetic mRNA can be effective, scalable, and generally well tolerated, with hundreds of millions of administered doses showing that short-lived protein production can trigger strong…